ELOXX PHARMACEUTICALS, INC. (ELOX) Shareholders’ equity 2023–2025
ELOXX PHARMACEUTICALS, INC. (ELOX) shareholders’ equity at each fiscal year-end, per SEC filings.
-$11.9MFY2025 · since FY2023: -$22.6M → -$11.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.9M | +51.1% |
| FY2024 | -$24.3M | -7.7% |
| FY2023 | -$22.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice